Literature DB >> 27688151

Low-level expression of human ACAT2 gene in monocytic cells is regulated by the C/EBP transcription factors.

Dongqing Guo1, Ming Lu2, Xihan Hu1, Jiajia Xu1, Guangjing Hu1, Ming Zhu1, Xiaowei Zhang1, Qin Li1, Catherine C Y Chang3, Tayuan Chang3, Baoliang Song1,4, Ying Xiong1, Boliang Li5.   

Abstract

Acyl-coenzyme A:cholesterol acyltransferases (ACATs) are the exclusive intracellular enzymes that catalyze the formation of cholesteryl/steryl esters (CE/SE). In our previous work, we found that the high-level expression of human ACAT2 gene with the CpG hypomethylation of its whole promoter was synergistically regulated by two transcription factors Cdx2 and HNF1α in the intestine and fetal liver. Here, we first observed that the specific CpG-hypomethylated promoter was correlated with the low expression of human ACAT2 gene in monocytic cell line THP-1. Then, two CCAAT/enhancer binding protein (C/EBP) elements within the activation domain in the specific CpG-hypomethylation promoter region were identified, and the expression of ACAT2 in THP-1 cells was evidently decreased when the C/EBP transcription factors were knock-downed using RNAi technology. Furthermore, ChIP assay confirmed that C/EBPs directly bind to their elements for low-level expression of human ACAT2 gene in THP-1 cells. Significantly, the increased expressions of ACAT2 and C/EBPs were also found in macrophages differentiated from both ATRA-treated THP-1 cells and cultured human blood monocytes. These results demonstrate that the low-level expression of human ACAT2 gene with specific CpG-hypomethylated promoter is regulated by the C/EBP transcription factors in monocytic cells, and imply that the lowly expressed ACAT2 catalyzes the synthesis of certain CE/SE that are assembled into lipoproteins for the secretion.
© The Author 2016. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ACAT2 expression; C/EBP; cis element; monocytic cell; promoter-CpG methylation

Mesh:

Substances:

Year:  2016        PMID: 27688151      PMCID: PMC5091289          DOI: 10.1093/abbs/gmw091

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  39 in total

1.  Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice.

Authors:  V Meiner; C Tam; M D Gunn; L M Dong; K H Weisgraber; S Novak; H M Myers; S K Erickson; R V Farese
Journal:  J Lipid Res       Date:  1997-09       Impact factor: 5.922

2.  MiR-9 reduces human acyl-coenzyme A:cholesterol acyltransferase-1 to decrease THP-1 macrophage-derived foam cell formation.

Authors:  Jiajia Xu; Guangjing Hu; Ming Lu; Ying Xiong; Qin Li; Catherine C Y Chang; Baoliang Song; Tayuan Chang; Boliang Li
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-09-12       Impact factor: 3.848

3.  Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice.

Authors:  K K Buhman; M Accad; S Novak; R S Choi; J S Wong; R L Hamilton; S Turley; R V Farese
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

4.  ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice.

Authors:  Richard G Lee; Ramesh Shah; Janet K Sawyer; Robert L Hamilton; John S Parks; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

5.  Excess TNF-α in the blood activates monocytes with the potential to directly form cholesteryl ester-laden cells.

Authors:  Ming Zhu; Lei Lei; Zhenhua Zhu; Qin Li; Dongqing Guo; Jiajia Xu; Jia Chen; Huifang Sha; Xiaowei Zhang; Xinying Yang; Baoliang Song; Boliang Li; Yan Yan; Ying Xiong
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-15       Impact factor: 3.848

6.  ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesterol homeostasis.

Authors:  Joyce J Repa; Kimberly K Buhman; Robert V Farese; John M Dietschy; Stephen D Turley
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

7.  Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells.

Authors:  C C Chang; H Y Huh; K M Cadigan; T Y Chang
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

8.  Insulin induces human acyl-coenzyme A: cholesterol acyltransferase1 gene expression via MAP kinases and CCAAT/enhancer-binding protein α.

Authors:  Jing Ge; Wei Zhai; Bei Cheng; Ping He; Benling Qi; Han Lu; Yongli Zeng; Xin Chen
Journal:  J Cell Biochem       Date:  2013-09       Impact factor: 4.429

9.  A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth.

Authors:  Ming Lu; Xi-Han Hu; Qin Li; Ying Xiong; Guang-Jing Hu; Jia-Jia Xu; Xiao-Nan Zhao; Xi-Xiao Wei; Catherine C Y Chang; Yin-Kun Liu; Fa-Jun Nan; Jia Li; Ta-Yuan Chang; Bao-Liang Song; Bo-Liang Li
Journal:  J Mol Cell Biol       Date:  2013-10-26       Impact factor: 6.216

10.  CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation.

Authors:  Thu-Hang Pham; Sabine Langmann; Lucia Schwarzfischer; Carol El Chartouni; Monika Lichtinger; Maja Klug; Stefan W Krause; Michael Rehli
Journal:  J Biol Chem       Date:  2007-05-31       Impact factor: 5.157

View more
  1 in total

1.  The ACAT2 expression of human leukocytes is responsible for the excretion of lipoproteins containing cholesteryl/steryl esters.

Authors:  Dongqing Guo; Xiaowei Zhang; Qin Li; Lei Qian; Jiajia Xu; Ming Lu; Xihan Hu; Ming Zhu; Catherine C Y Chang; Baoliang Song; Tayuan Chang; Ying Xiong; Boliang Li
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-09-29       Impact factor: 3.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.